International Commission on the Clinical Use of Human Germline Genome Editing

Tue, December 03, 2019

The International Commission on the Clinical Use of Human Germline Genome Editing has been convened by the U.S. National Academy of Medicine (NAM), the U.S. National Academy of Sciences (NAS), and the Royal Society of the U.K., with the participation of science and medical academies around the world, to develop a framework for scientists, clinicians, and regulatory authorities to consider when assessing potential clinical applications of human germline genome editing. The framework will identify a number of scientific, medical, and ethical requirements that should be considered, and could inform the development of a potential pathway from research to clinical use — if society concludes that heritable human genome editing applications are acceptable.

The second meeting of the commission took place in London, UK, on 14-15 November 2019, and it feratured three speakers nominated by IAP:
  • Sonia Abdelhak (Institut Pasteur de Tunis, Tunisia)
  • Fabiana Arzuaga (Ministry of Science, Technology and Productive Innovation, Argentina)
  • Muntaser Ibrahim (University of Khartoum, Sudan)

The webcast of the event is available here: 

November 14

November 15